Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Billington Phillip G
 2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2019		 3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [HCA]
(Last)
(First)
(Middle)
ONE PARK PLAZA		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP-Internal Audit Services
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NASHVILLE, TN 37203		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 24,840.4098 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right   (2) 02/08/2022 Common Stock 7,500 $ 22.95 D  
Stock Appreciation Right   (3) 02/08/2022 Common Stock 7,500 $ 22.95 D  
Stock Appreciation Right   (4) 02/06/2023 Common Stock 8,500 $ 37.18 D  
Stock Appreciation Right   (5) 02/06/2023 Common Stock 8,075 $ 37.18 D  
Stock Appreciation Right   (6) 02/05/2024 Common Stock 6,500 $ 47.97 D  
Stock Appreciation Right   (7) 02/05/2024 Common Stock 5,525 $ 47.97 D  
Stock Appreciation Right   (8) 02/04/2025 Common Stock 8,000 $ 68.96 D  
Stock Appreciation Right   (9) 01/29/2026 Common Stock 7,010 $ 69.58 D  
Stock Appreciation Right   (10) 02/01/2027 Common Stock 7,340 $ 81.96 D  
Stock Appreciation Right   (11) 01/31/2028 Common Stock 9,150 $ 101.16 D  
Stock Appreciation Right   (12) 10/31/2028 Common Stock 13,730 $ 133.53 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Billington Phillip G
ONE PARK PLAZA
NASHVILLE, TN 37203		       SVP-Internal Audit Services  

Signatures

/s/ Virginia Chase Crocker, Attorney-in-Fact 01/10/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 1,463.4098 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
(2) The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
(3) The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
(4) The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
(5) The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
(6) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
(7) The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
(8) The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
(9) The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
(10) The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.
(11) The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.
(12) The stock appreciation rights vest in four equal annual installments beginning on October 31, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.